What Researchers Did
Researchers surveyed directors of 13 accredited hyperbaric units in Australia and New Zealand to document current practices for blood glucose management in diabetic patients undergoing hyperbaric oxygen treatment.
What They Found
Of the 13 surveyed hyperbaric units, 12 routinely managed patients with diabetes. Three-quarters (9/12) of these units used a pre-hyperbaric oxygen treatment blood glucose threshold of < 4 mmol/L, indicating considerable variability in management practices.
What This Means for Canadian Patients
Canadian patients with diabetes undergoing hyperbaric oxygen treatment may experience similar variability in blood glucose management practices. Standardized guidelines could improve safety and optimize care for these patients by ensuring consistent and evidence-based protocols.
Canadian Relevance
This study has no direct Canadian connection as it was conducted exclusively in Australia and New Zealand.
Study Limitations
A limitation of this study is its reliance on self-reported survey data from a specific geographic region, which may not fully capture the complexities of clinical practice or be generalizable worldwide.